Navigation

2003/052 Latest NICE guidance offers new hope for people with chronic myeloid leukaemia

The National Institute for Clinical Excellence (NICE) has today (22nd October) issued guidance on the use of imatinib for chronic myeloid leukaemia (CML) within the NHS in England and Wales.

This page was last updated: 29 April 2009

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.